FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

732996003: Implant (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498537011 Implant (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498538018 Implant en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Implant Is a Unit of presentation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation False Implant Inferred relationship Existential restriction modifier
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Has unit of presentation True Implant Inferred relationship Existential restriction modifier
Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely levonorgestrel 75 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely levonorgestrel 75 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation False Implant Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation False Implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation False Implant Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone 700 microgram/1 each prolonged-release ocular implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely dexamethasone 700 microgram/1 each prolonged-release ocular implant (clinical drug) Has unit of presentation True Implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation False Implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation False Implant Inferred relationship Existential restriction modifier
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation False Implant Inferred relationship Existential restriction modifier
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant Inferred relationship Existential restriction modifier
Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely fluocinolone acetonide 590 microgram/1 each prolonged-release ocular implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely fluocinolone acetonide 590 microgram/1 each prolonged-release ocular implant (clinical drug) Has unit of presentation True Implant Inferred relationship Existential restriction modifier
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) Has unit of presentation True Implant Inferred relationship Existential restriction modifier
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) Has presentation strength denominator unit True Implant Inferred relationship Existential restriction modifier 1
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has unit of presentation True Implant Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start